Synthetic Cannabinoid Ajulemic Acid Shows Potent Antifibrotic Effects in Systemic Sclerosis Models
Ajulemic acid antifibrotic effects have shown promise in reducing collagen synthesis in systemic sclerosis models. This synthetic cannabinoid activates PPAR-γ to inhibit fibrogenesis. Research supports its potential as a treatment for scleroderma-related…
The synthetic cannabinoid WIN55,212-2 mesylate decreases inflammatory mediators in rheumatoid arthritis synovial fibroblasts
The synthetic cannabinoid WIN55212-2 mesylate plays a significant role in reducing inflammatory mediators in rheumatoid arthritis synovial fibroblasts. This compound modulates immune cell activity to protect joint tissues. Understanding its mechanisms…
Synthetic cannabinoids cause more convulsion and hypothermia in mice than cannabis-derived cannabinoids.
Synthetic cannabinoids toxicity causes more convulsions and hypothermia in mice than cannabis-derived cannabinoids. This study compares effects of synthetic and endogenous cannabinoids on biological systems. Findings reveal synthetic cannabinoids…